Personal tools

Coexpression cluster:C196

From FANTOM5_SSTAR

Revision as of 11:53, 19 October 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C196_testicular_iPS_H9_teratocarcinoma_HES3GFP_choriocarcinoma_endometrial



Phase1 CAGE Peaks

Hg19::chr10:126138597..126138612,-p1@NKX1-2
Hg19::chr10:17421411..17421428,-p@chr10:17421411..17421428
-
Hg19::chr10:88715938..88715944,+p@chr10:88715938..88715944
+
Hg19::chr11:571738..571745,+p@chr11:571738..571745
+
Hg19::chr11:68458387..68458424,+p3@GAL
Hg19::chr12:122018746..122018755,+p10@ENST00000541574
Hg19::chr12:4128088..4128115,+p@chr12:4128088..4128115
+
Hg19::chr13:113679015..113679022,+p48@MCF2L
Hg19::chr13:113679026..113679032,+p51@MCF2L
Hg19::chr14:20777397..20777403,+p@chr14:20777397..20777403
+
Hg19::chr14:23019467..23019489,+p@chr14:23019467..23019489
+
Hg19::chr14:23676550..23676564,-p@chr14:23676550..23676564
-
Hg19::chr14:65443907..65443910,-p@chr14:65443907..65443910
-
Hg19::chr14:67958000..67958046,-p@chr14:67958000..67958046
-
Hg19::chr15:89090517..89090532,-p@chr15:89090517..89090532
-
Hg19::chr15:97421623..97421630,+p@chr15:97421623..97421630
+
Hg19::chr16:56703691..56703702,+p4@MT1H
Hg19::chr16:60118628..60118633,-p@chr16:60118628..60118633
-
Hg19::chr17:17495344..17495361,-p18@PEMT
Hg19::chr17:17495366..17495387,-p10@PEMT
Hg19::chr17:77923773..77923782,-p@chr17:77923773..77923782
-
Hg19::chr17:80713164..80713169,+p@chr17:80713164..80713169
+
Hg19::chr19:1584912..1584913,-p6@M77818
Hg19::chr19:20334742..20334750,-p@chr19:20334742..20334750
-
Hg19::chr19:20349204..20349207,-p@chr19:20349204..20349207
-
Hg19::chr19:20349209..20349221,-p@chr19:20349209..20349221
-
Hg19::chr19:20406681..20406707,+p@chr19:20406681..20406707
+
Hg19::chr19:22041202..22041205,+p@chr19:22041202..22041205
+
Hg19::chr19:22041270..22041282,+p@chr19:22041270..22041282
+
Hg19::chr19:282788..282832,-p@chr19:282788..282832
-
Hg19::chr19:40431284..40431296,-p@chr19:40431284..40431296
-
Hg19::chr19:52932435..52932443,+p3@ZNF534
Hg19::chr19:55405124..55405130,+p@chr19:55405124..55405130
+
Hg19::chr1:160160001..160160019,+p9@CASQ1
Hg19::chr1:161392010..161392029,+p@chr1:161392010..161392029
+
Hg19::chr1:27385778..27385789,+p@chr1:27385778..27385789
+
Hg19::chr1:27386571..27386581,+p@chr1:27386571..27386581
+
Hg19::chr1:29513362..29513370,-p@chr1:29513362..29513370
-
Hg19::chr1:36906474..36906481,-p6@OSCP1
Hg19::chr1:52902618..52902666,-p11@ZCCHC11
Hg19::chr1:70833635..70833640,+p@chr1:70833635..70833640
+
Hg19::chr20:18304432..18304433,-p@chr20:18304432..18304433
-
Hg19::chr21:44199834..44199841,+p@chr21:44199834..44199841
+
Hg19::chr22:38716047..38716051,-p@chr22:38716047..38716051
-
Hg19::chr22:44547044..44547092,+p@chr22:44547044..44547092
+
Hg19::chr2:15359103..15359113,-p@chr2:15359103..15359113
-
Hg19::chr2:188430478..188430496,-p16@TFPI
Hg19::chr2:202004516..202004536,+p68@CFLAR
Hg19::chr3:121286771..121286805,+p1@ARGFX
Hg19::chr3:12200340..12200366,-p2@TIMP4
Hg19::chr3:123033372..123033391,-p12@ADCY5
Hg19::chr3:123033401..123033424,-p10@ADCY5
Hg19::chr3:47155553..47155568,-p@chr3:47155553..47155568
-
Hg19::chr4:151970682..151970693,-p@chr4:151970682..151970693
-
Hg19::chr4:165953174..165953189,+p1@TRIM60
Hg19::chr4:24509678..24509683,+p@chr4:24509678..24509683
+
Hg19::chr4:4049981..4049985,-p@chr4:4049981..4049985
-
Hg19::chr5:133984068..133984080,+p14@SEC24A
Hg19::chr5:134260439..134260448,-p@chr5:134260439..134260448
-
Hg19::chr5:23238053..23238064,-p@chr5:23238053..23238064
-
Hg19::chr5:75493822..75493845,-p@chr5:75493822..75493845
-
Hg19::chr5:81277144..81277166,+p@chr5:81277144..81277166
+
Hg19::chr6:15022142..15022148,-p@chr6:15022142..15022148
-
Hg19::chr6:161304316..161304322,+p@chr6:161304316..161304322
+
Hg19::chr6:43392420..43392440,+p@chr6:43392420..43392440
+
Hg19::chr6:6032547..6032560,-p@chr6:6032547..6032560
-
Hg19::chr6:73933968..73933992,-p@chr6:73933968..73933992
-
Hg19::chr6:73934008..73934023,-p@chr6:73934008..73934023
-
Hg19::chr6:73935069..73935097,-p6@KHDC1L
Hg19::chr6:73935132..73935142,-p7@KHDC1L
Hg19::chr6:73935150..73935162,-p3@KHDC1L
Hg19::chr6:73935163..73935172,-p4@KHDC1L
Hg19::chr6:73935193..73935256,-p1@KHDC1L
Hg19::chr6:74072375..74072388,+p1@C6orf221
Hg19::chr7:152251017..152251036,+p@chr7:152251017..152251036
+
Hg19::chr7:30956234..30956256,-p@chr7:30956234..30956256
-
Hg19::chr7:57509877..57509895,+p1@ZNF716
Hg19::chr7:57509910..57509917,+p2@ZNF716
Hg19::chr8:129629467..129629494,-p@chr8:129629467..129629494
-
Hg19::chr8:145700990..145701000,-p4@FOXH1
Hg19::chr8:145701030..145701041,-p3@FOXH1
Hg19::chr8:27834637..27834645,-p@chr8:27834637..27834645
-
Hg19::chr8:37685815..37685822,+p@chr8:37685815..37685822
+
Hg19::chr8:37685860..37685864,+p@chr8:37685860..37685864
+
Hg19::chr9:134782494..134782517,+p@chr9:134782494..134782517
+
Hg19::chr9:85470564..85470567,-p@chr9:85470564..85470567
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
germ line cell1.79e-757
germ cell1.79e-757
embryonic stem cell4.63e-275
melanocyte4.24e-1410
melanoblast4.24e-1410
pigment cell2.29e-1014
neurecto-epithelial cell1.52e-0720
Uber Anatomy
Ontology termp-valuen
testis3.66e-668
male reproductive organ2.24e-4811
gonad9.82e-2621
indifferent external genitalia9.82e-2621
indifferent gonad9.82e-2621
gonad primordium9.82e-2621
external genitalia1.34e-2422
male organism1.34e-2422
male reproductive system1.34e-2422
body cavity4.14e-1246
reproductive organ1.25e-1148
body cavity or lining2.10e-1149
body cavity precursor2.12e-1054
reproductive structure1.45e-0959
reproductive system1.45e-0959
anatomical cavity2.88e-0961
Disease
Ontology termp-valuen
germ cell and embryonal cancer1.34e-2422
germ cell cancer1.34e-2422


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data